Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: Reappraisal of epidemiological, clinical, and pathological features - 10/08/11
, Onofre Sanmartín, MD a, Rafael Botella-Estrada, MD a, Nicole N. Balmer, MD b, Carlos Serra-Guillén, MD a, Elisabeth Gomez-Moyano, MD c, Victor Traves-Zapata, MD a, Celia Requena, MD a, Eduardo Nagore, MD a, Beatriz Llombart-Cussac, MD a, Carlos Guillen-Barona, MD a
Reprint requests: Antonio Martorell-Calatayud, MD, Dermatology Department, Instituto Valenciano de Oncologia, San Jose de la Montaña Street, 14, 46008, Valencia, Spain.Abstract |
Background |
A characteristic cutaneous eruption related to the use of cytostatic chemotherapeutic drugs has been described in the literature. This condition appears to be characterized by an erythematous eruption, primarily affecting the intertriginous areas bilaterally, together with eccrine squamous syringometaplasia as the main histologic feature.
Objective |
We sought to establish the epidemiologic, clinical, and histologic characteristics of this poorly defined chemotherapy drug-related eruption.
Methods |
Retrospective data were collected from 21 consecutive patients with this clinical and histopathologic pattern who attended an oncology center between January 1999 and September 2009. Two skin biopsy specimens were obtained from all patients, with the first being taken within 24 hours of onset, and the second 72 to 96 hours after onset.
Results |
The patients analyzed were predominantly female (72%), with a mean age of 52 years (range 10-69 years). The lesions presented clinically as bilateral erythematous plaques affecting both axillae (95%), groin (88%), and side aspects of the neck (48%). The main histologic feature in all cases was eccrine squamous syringometaplasia, characterized by the transformation of the eccrine cuboidal epithelium into two or more layers of squamous cells with intercellular bridges. The onset of the eruption appeared within 30 days (range 2-30 days) after the initiation of the cytostatic agent infusion. The lesions resolved with desquamation and postinflammatory hyperpigmentation. The same cutaneous pattern recurred in up to 50% of patients in whom the oncologist reintroduced the cytostatic treatment.
Limitations |
Small sample size was a limitation.
Conclusions |
We suggest the term “chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia” to describe this distinctive entity, which is primarily associated with pegylated liposomal doxorubicin infusions and chemotherapeutic regimens used in autologous bone-marrow transplantation.
Le texte complet de cet article est disponible en PDF.Key words : cytostatic agent, drug reaction, eccrine squamous syringometaplasia, intertriginous rash, oncology, pegylated liposomal doxorubicin
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 64 - N° 6
P. 1092-1103 - juin 2011 Retour au numéro
Article précédent
- The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions
- Steven R. Feldman, Jerry Tan, Yves Poulin, Thomas Dirschka, Nabil Kerrouche, Vasant Manna
- Elephantiasis nostras verrucosa: An institutional analysis of 21 cases
- Steven M. Dean, Matthew J. Zirwas, Anthony Vander Horst
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?